Friday, Apr 26, 2024 | Last Update : 06:44 PM IST
gilead sciences inc’s
Cipla to price remdesivir version for COVID-19 under Rs 5,000
Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.
24 Jun 2020 9:16 AM
1 of 1
ADVERTISEMENT
ADVERTISEMENT
more
Columns
Analysis reveals Prime Minister Modi's diminishing impact as opposition highlights governance failures and divisive tactics.
Senior IPS Officer Y. Puran Kumar Raises Eyebrows with Complaint of Car Discrimination Amid Lok Sabha Elections
Modi's "Guarantee 2024" vs Congress' "Nyay Patra" - A Clash of Narratives
Exploring the historical context and implications of the term "Hindu Rashtra" in light of constitutional and legal frameworks.